Literature DB >> 29516297

Physico-chemical properties influence the functions and efficacy of commercial bovine lactoferrins.

Luigi Rosa1, Antimo Cutone1,2, Maria Stefania Lepanto1, Mellani Jinnett Scotti1, Maria Pia Conte1, Rosalba Paesano3, Piera Valenti4.   

Abstract

Human and bovine lactoferrin (hLf and bLf) are multifunctional iron-binding glycoprotein constitutively synthesized and secreted by glandular epithelial cells and by neutrophils following induction. HLf and bLf possess very high similarity of sequence. Therefore, most of the in vitro and in vivo studies are carried out with commercial bLf (cbLf), available in large quantities and recognized by Food and Drug Administration (FDA, USA) as a safe substance. Physico-chemical heterogeneity of different cbLf preparations influences their effectiveness. CbLf iron-saturation affects thermal stability and resistance to proteolysis. Moreover, other metal ions such as Al(III), Cu(II), Mg(II), Mn(II), Zn(II) are chelated by cbLf, even if at lower affinity than Fe(III). Ca(II) is also sequestered by the carboxylate groups of sialic acid present on glycan chains of cbLf thus provoking the release of LPS, contributing to bactericidal activity. Similarly to more than 50% of eukaryotic proteins, cbLf possesses five N-glycosylation sites, also contributing to the resistance to proteolysis and, putatively, to the protection of intestinal mucosa from pathogens. CbLfs possess several functions as anti-microbial, anti-biofilm, anti-adhesive, anti-invasive and anti-inflammatory activities. They are also relevant modulators of iron and inflammatory homeostasis. However, the efficacy of cbLfs in exerting several functions can be erratic mainly depending from integrity, degree of iron and other metal ions saturation, N-glycosylation sites and chains, desialylated forms, Ca(II) sequestration, presence of contaminants and finally the ability to enter inside nucleus.

Entities:  

Keywords:  Anaemia of inflammation; Commercial bovine lactoferrins; Iron deficiency anaemia; Lactoferrin; Lipopolysaccharide release; Metal-binding ability

Mesh:

Substances:

Year:  2018        PMID: 29516297     DOI: 10.1007/s10534-018-0092-8

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  9 in total

Review 1.  Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer's Disease: Implications for Diagnosis and Treatment.

Authors:  Francesco Bruno; Antonio Malvaso; Sonia Canterini; Amalia Cecilia Bruni
Journal:  Antibiotics (Basel)       Date:  2022-05-28

2.  Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates.

Authors:  Tyra M Avery; RaNashia L Boone; Jacky Lu; Sabrina K Spicer; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Shannon D Manning; Leon Dent; Dana Marshall; Steven M Damo; Steven D Townsend; Jennifer A Gaddy
Journal:  ACS Infect Dis       Date:  2021-06-09       Impact factor: 5.084

Review 3.  Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.

Authors:  Romina Mancinelli; Luigi Rosa; Antimo Cutone; Maria Stefania Lepanto; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Piera Valenti
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

4.  Bovine Lactoferrin Pre-Treatment Induces Intracellular Killing of AIEC LF82 and Reduces Bacteria-Induced DNA Damage in Differentiated Human Enterocytes.

Authors:  Maria Stefania Lepanto; Luigi Rosa; Antimo Cutone; Mellani Jinnett Scotti; Antonietta Lucia Conte; Massimiliano Marazzato; Carlo Zagaglia; Catia Longhi; Francesca Berlutti; Giovanni Musci; Piera Valenti; Maria Pia Conte
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

5.  A Novel Human Recombinant Lactoferrin Inhibits Lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.

Authors:  Paulina Olszewska; Barbara Pazdrak; Marian L Kruzel
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-11-08       Impact factor: 4.291

Review 6.  Neuroprotective Role of Lactoferrin during Early Brain Development and Injury through Lifespan.

Authors:  Gabriel Henrique Schirmbeck; Stéphane Sizonenko; Eduardo Farias Sanches
Journal:  Nutrients       Date:  2022-07-17       Impact factor: 6.706

7.  Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.

Authors:  Maria Stefania Lepanto; Luigi Rosa; Antimo Cutone; Maria Pia Conte; Rosalba Paesano; Piera Valenti
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

8.  Aerosolized Bovine Lactoferrin Counteracts Infection, Inflammation and Iron Dysbalance in A Cystic Fibrosis Mouse Model of Pseudomonas aeruginosa Chronic Lung Infection.

Authors:  Antimo Cutone; Maria Stefania Lepanto; Luigi Rosa; Mellani Jinnett Scotti; Alice Rossi; Serena Ranucci; Ida De Fino; Alessandra Bragonzi; Piera Valenti; Giovanni Musci; Francesca Berlutti
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 9.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.